The present study aims to evaluate the inhibitory effects of Rha on leptin-induced VM in TNBC cells and to explore its potential as a novel therapeutic candidate for obesity-associated TNBC. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.